Both Amgen and Merck write quarterly checks and raise them every year, but only one has the portfoli

European committee backs Merck's Keytruda + Padcev combo for bladder cancer after Phase 3 trial

A biopharma giant, a chip maker, a delivery network, a trash hauler, and an oncology powerhouse walk

The Fed hiked to 4%, Generac jumped 40% on Amazon warrants, and more

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today launched Your Hive of

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the Europea

Opinion granted based on positive results from the Phase 3 KEYNOTE-B15 trial, which demonstrated imp

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Cana

Merck (MRK) closed at $147.17 in the latest trading session, marking a +1.56% move from the prior da

Merck (MRK), the pharmaceutical and oncology heavyweight, entered the next era of commercial space r

Moderna Inc. (NASDAQ: MRNA) shares are popping Thursday, extending a month-long rally that began wit

Moderna stock has more than doubled after its cancer-vaccine breakthrough. Now investors face the ha

Merck & Co (NYSE:MRK) has outperformed the market over the past 5 years by 3.02% on an annualize

Novo Nordisk taps Anthropic AI to speed medicine research, enhance software workflows, and implement

Forgent reports bumper quarter, Nvidia joins the AI safety debate, and more

PPH offers higher income and lower volatility, while BBH delivers stronger growth but with deeper dr

Eli Lilly and Merck both reported second quarter earnings, and the contrast could not be sharper. On

Merck & Co., Inc. NYSE: MRK Chairman and CEO Rob Davis said the company's “transformation is underwa

Merck & Co., Inc. (MRK) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcri

Moderna built an artificial intelligence that reads a patient's tumor and decides what that patient'

Perspective Therapeutics, Inc. ("Perspective," the "Company," "we," "us,

SEATTLE, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective,” the “Comp

Tempus CEO Eric Lefkofsky discusses the company's artificial intelligence-driven precision medicine

Income seekers can't go wrong with these companies.

Merck is expanding its pipeline and newer drug portfolio to offset Keytruda's 2028 LOE and drive lon

President Trump's Surgeon General nominee Dr. Nicole Saphier disclosed investments in Philip Mor

Retail investors often monitor the trading activity of members of Congress. Investors may want to pa

A congresswoman recently bought stocks connected to Warren Buffett and Elon Musk.

In the most recent trading session, Merck (MRK) closed at $144.71, indicating a -1.91% shift from th

September 9, 2026 records indicate that Representative Maria Elvira Salazar filed a purchase of Merc

HSBC analyst Rajesh Kumar maintains Merck & Co (NYSE:MRK) with a Buy and raises the price tar

Leerink Partners analyst Daina Graybosch maintains Merck & Co (NYSE:MRK) with a Outperform an

Medicare drug spending faces fresh pressure as more seniors hit the $2,000 cap, raising concerns ove

https://www.bloomberg.com/news/articles/2026-09-08/fda-s-acting-drug-vaccine-regulators-tapped-for-p

Inhibrx Biosciences reports Phase 2 HexAgon trial data showing improved response rates for INBRX-106

JPMorgan sees healthcare ETF flows reversing, with Eli Lilly and AbbVie among stocks that could bene

Guggenheim analyst Vamil Divan maintains Merck & Co (NYSE:MRK) with a Buy and raises the pric

Wells Fargo analyst Mohit Bansal maintains Merck & Co (NYSE:MRK) with a Overweight and raises

Summit Therapeutics' partner Akeso reported positive overall survival results for ivonescimab in

Moderna’s cancer vaccine breakthrough puts biotech, mRNA and genomics ETFs in focus. Here are the fu

https://www.who.int/news/item/28-08-2026-second-meeting-of-the-ihr-emergency-committee-on-the-epidem

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Moderna announces a $2 billion convertible senior note offering to fund its oncology business growth

Sunshine Biopharma outlines K1.1 mRNA pipeline updates, advancing dual oncology therapy to target co

Johnson credits Trump and Republicans for record low drug prices, stating Americans are seeing lower

Two unvaccinated Pennsylvania residents died of measles, the state’s first deaths in 35 years, as tr

Wolfe Research analyst Alexandria Hammond maintains Merck & Co (NYSE:MRK) with a Outperform a

Shares of Moderna are trading higher Tuesday morning, as Wall Street analysts upgrade their ratings

Argus Research analyst Jasper Hellweg maintains Merck & Co (NYSE:MRK) with a Buy and raises t

Court rejects Merck's lawsuit against Medicare drug price negotiations. Penalties for noncomplia